141 Views | 69 Downloads
Guido Silvestri: gsilves@emory.edu
Author contributions: D.G.C., M.P., D.B.W., H.C.J.E., and G.S. designed research; D.G.C., K.S.W., J. Yu, and S.T.L. performed research; J. Yan, M.P.M., N.Y.S., D.B.W., and H.C.J.E. contributed new reagents/analytic tools; D.G.C., K.S.W., J. Yu, and B.A.J. analyzed data; and D.G.C., D.B.W., H.C.J.E., and G.S. wrote the paper.
We thank the Emory Center for AIDS Research Virology Core for technical support.
J. Yan, M.P.M., and N.Y.S. are employees of Inovio Pharmaceuticals.
D.B.W. has received speaking honoraria and direct payments or stock or stock options as fees for consulting (including service on scientific review committees and advisory boards) with Pfizer, Medimmune, Inovio, Merck, VGXI, OncoSec, Roche, Ferring, Novartis, Aldevron, and possibly others. Licensing of technology from his laboratory has created over 150 jobs in the biotech/pharma sector.
This work was supported by National Institutes of Health (NIH) Grant HIVRAD P01 A080082 (to H.C.J.E. and G.S.) and by NIH/National Center for Research Resources Grant P51RR000165 and currently is supported by the Office of Research Infrastructure Programs Grant OD P51OD011132 to the Yerkes National Primate Research Center. N.Y.S., J. Yan, and M.P.M. were supported in part by NIH/National Institute of Allergy and Infection Diseases/Division of AIDS Grant HHSN272200800063C for HIV vaccine development.
D.B.W. has grant funding, participates in industry collaborations, has received speaking honoraria, and fees for consulting.
National Academy of Sceinces